ZNF717

Chr 3

zinc finger protein 717

Also known as: OB1, X17, ZNF838

The protein is a KRAB zinc-finger transcriptional regulator that binds nucleic acids and controls cellular functions including proliferation, differentiation, and apoptosis. Mutations cause neurodevelopmental disorder with epilepsy, which follows an autosomal dominant inheritance pattern. The gene shows low constraint against loss-of-function variants, suggesting the disorder may not result from simple protein loss.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
11
P/LP submissions
0%
P/LP missense
1.91
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryZNF717
Population Constraint (gnomAD)
Low constraint (pLI 0.02) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 9 VUS of 37 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.91LOEUF
pLI 0.019
Z-score -0.35
OE 1.30 (0.431.91)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.91Z-score
OE missense 1.48 (1.311.67)
186 obs / 125.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.30 (0.431.91)
00.351.4
Missense OE1.48 (1.311.67)
00.61.4
Synonymous OE1.55
01.21.6
LoF obs/exp: 2 / 1.5Missense obs/exp: 186 / 125.8Syn Z: -2.88
DN
0.90top 5%
GOF
0.86top 5%
LOF
0.2387th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

37 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic2
VUS9
Likely Benign10
Benign5
9
Pathogenic
2
Likely Pathogenic
9
VUS
10
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
8
1
9
Likely Pathogenic
0
0
2
0
2
VUS
0
2
7
0
9
Likely Benign
0
1
4
5
10
Benign
0
1
4
0
5
Total0425635

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZNF717 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC